Authors: Voutsas, IF Baxevanis, CN Gritzapis, AD Missitzis, I Stathopoulos, GP Archodakis, G Banis, C Voelter, W Papamichail, M

Citation: If. Voutsas et al., Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas, CANCER IMMU, 49(8), 2000, pp. 449-458

Authors: Baxevanis, CN Voutsas, IF Tsitsilonis, OE Gritzapis, AD Sotiriadou, R Papamichail, M

Citation: Cn. Baxevanis et al., Tumor-specific CD4(+) T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor, J IMMUNOL, 164(7), 2000, pp. 3902-3912

Authors: Baxevanis, CN Voutsas, IF Tsitsilonis, OE Tsiatas, ML Gritzapis, AD Papamichail, M

Citation: Cn. Baxevanis et al., Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice, EUR J IMMUN, 30(7), 2000, pp. 1957-1966

Authors: Baxevanis, CN Spanakos, G Voutsas, IF Gritzapis, AD Tsitsilonis, OE Mamalaki, A Papamichail, M

Citation: Cn. Baxevanis et al., Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin alpha, CANCER IMMU, 48(2-3), 1999, pp. 71-84